Spaulding Clinical
Registered Principal Details
Business Or Interest:
Phase 1 drug testing
Lobbying Interests:
Matters related to employment status of drug testing participants
CEO Name:
Cassandra Erato
Phase 1 drug testing
Lobbying Interests:
Matters related to employment status of drug testing participants
CEO Name:
Cassandra Erato
Contact
BZ
Bonnie Zanow
525 S. Silverbrook Drive
West Bend , WI 53095
(262) 334-6020
bonnie.zanow@spauldingclinical.com
525 S. Silverbrook Drive
West Bend , WI 53095
(262) 334-6020
bonnie.zanow@spauldingclinical.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Jason Childress | Exclusive Duties No | Authorized On 12/23/2022 | Withdrawn On N/A |
| Alicia Schweitzer | Exclusive Duties No | Authorized On 12/23/2022 | Withdrawn On N/A |
| Joe Leibham | Exclusive Duties No | Authorized On 12/23/2022 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 398
Relating to: participants in clinical research trials. (FE)
Bill Text and History
1/3/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: participants in clinical research trials. (FE)
Bill Text and History
For
Notification Date1/3/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 387
Relating to: participants in clinical research trials. (FE)
Bill Text and History
8/10/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: participants in clinical research trials. (FE)
Bill Text and History
For
Notification Date8/10/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Matters related to the status of test participants.
Matters related to the status of test participants.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/19/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/19/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2023 January - June |
2023 July - December |
2024 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2023 January - June $16,990.00 |
2023 July - December $32,400.00 |
2024 January - June $27,000.00 |
Total $76,390.00 |
| Total Hours Communicating | 2023 January - June 12.90 |
2023 July - December 5.00 |
2024 January - June 14.90 |
Total 32.80 |
| Total Hours Other | 2023 January - June 16.50 |
2023 July - December 14.30 |
2024 January - June 3.10 |
Total 33.90 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: participants in clinical research trials. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 50% |
2024 January - June 40% |
2024 July - December |
Total 25% |
Relating to: participants in clinical research trials. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 50% |
2024 January - June 40% |
2024 July - December |
Total 25% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 95% |
2023 July - December |
2024 January - June 20% |
2024 July - December |
Total 47% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.